In Vitro Activities of Aztreonam-Avibactam, Eravacycline, Cefoselis, and Other Comparators against Clinical Enterobacterales Isolates: a Multicenter Study in China, 2019

• DOI: 10.1128/spectrum.04873-22
• Publication Date: 2023-05-15T14:00:18Z
• Authors: Jiawei Chen; Yong Liu; Wei Jia; Xuesong Xu; Guizhen Sun; Tong Wang; Jin Li; Ge Zhang; Ran Jing; Hongli Sun; Yingchun Xu; Yali Liu
• Keywords: Aztreonam; Ceftazidime/avibactam

Infections caused by multidrug-resistant (MDR) Enterobacterales , especially carbapenem-resistant (CRE), have been a challenging clinical problem due to the limited therapeutic options. Therefore, need develop novel antimicrobial agents and evaluate their activities against in vitro is urgent.